| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2024 | Jun 20, 2024 | Gossamer Bio, Inc. | CFO | Buy | 95.0 | +100,000 | 26.32% | ✗ | $59.1K |
| Mar 27, 2024 | Mar 28, 2024 | Gossamer Bio, Inc. | CFO | Sell | 47.5 | -6,430 | -1.34% | ✗ | $7.4K |
| Nov 13, 2023 | Nov 14, 2023 | Gossamer Bio, Inc. | CFO | Buy | 95.0 | +200,000 | 71.64% | ✗ | $112.9K |
| Apr 4, 2023 | Apr 5, 2023 | Gossamer Bio, Inc. | CFO | Buy | 95.0 | +55,000 | 32.32% | ✗ | $56.1K |
| Mar 20, 2023 | Mar 22, 2023 | Gossamer Bio, Inc. | CFO | Buy | 91.3 | +50,000 | 41.61% | ✗ | $48.4K |
| Jul 15, 2022 | Jul 15, 2022 | Gossamer Bio, Inc. | CFO | Buy | 95.0 | +13,869 | 13.05% | ✗ | $100K |
| Mar 23, 2022 | Mar 24, 2022 | Gossamer Bio, Inc. | CFO | Sell | 42.5 | -10,722 | -9.16% | ✗ | $95.6K |
| Mar 23, 2021 | Mar 25, 2021 | Gossamer Bio, Inc. | CFO | Sell | 42.5 | -5,490 | -4.48% | ✗ | $52K |
| Oct 14, 2020 | Oct 14, 2020 | Gossamer Bio, Inc. | CFO | Buy | 83.8 | +3,000 | 4.03% | ✗ | $30K |
| Jun 23, 2020 | Jun 23, 2020 | Gossamer Bio, Inc. | CFO | Buy | 83.8 | +2,000 | 2.76% | ✗ | $25.9K |
| Dec 3, 2019 | Dec 3, 2019 | Protagonist Therapeutics, Inc | Director | Buy | 91.3 | +8,000 | 80.00% | ✗ | $45.6K |
| Sep 26, 2019 | Sep 26, 2019 | Gossamer Bio, Inc. | CFO | Buy | 83.8 | +1,121 | 4.51% | ✗ | $18.8K |
| May 30, 2019 | Jun 3, 2019 | Gossamer Bio, Inc. | CFO | Buy | 83.8 | +1,000 | 4.19% | ✗ | $18.7K |
| Feb 12, 2019 | Feb 12, 2019 | Gossamer Bio, Inc. | CFO | Buy | 95.0 | +6,000 | 33.56% | ✗ | $96K |
| May 16, 2017 | May 17, 2018 | Protagonist Therapeutics, Inc | Director | Buy | 95.0 | +10,000 | 100.00% | ✗ | $64.6K |